378 related articles for article (PubMed ID: 15645123)
1. Interstitial loss and gain of sequences on chromosome 22 in meningiomas with normal karyotype.
Prowald A; Wemmert S; Biehl C; Storck S; Martin T; Henn W; Ketter R; Meese E; Zang KD; Steudel WI; Urbschat S
Int J Oncol; 2005 Feb; 26(2):385-93. PubMed ID: 15645123
[TBL] [Abstract][Full Text] [Related]
2. A role for telomeric and centromeric instability in the progression of chromosome aberrations in meningioma patients.
Sawyer JR; Husain M; Pravdenkova S; Krisht A; Al-Mefty O
Cancer; 2000 Jan; 88(2):440-53. PubMed ID: 10640979
[TBL] [Abstract][Full Text] [Related]
3. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
[TBL] [Abstract][Full Text] [Related]
4. Lack of genetic and epigenetic changes in meningiomas without NF2 loss.
van Tilborg AA; Morolli B; Giphart-Gassler M; de Vries A; van Geenen DA; Lurkin I; Kros JM; Zwarthoff EC
J Pathol; 2006 Mar; 208(4):564-73. PubMed ID: 16353169
[TBL] [Abstract][Full Text] [Related]
5. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
[TBL] [Abstract][Full Text] [Related]
7. Multiple meningioma with different grades of malignancy: case report with genetic analysis applying single-nucleotide polymorphism array and classical cytogenetics.
Mocker K; Holland H; Ahnert P; Schober R; Bauer M; Kirsten H; Koschny R; Meixensberger J; Krupp W
Pathol Res Pract; 2011 Jan; 207(1):67-72. PubMed ID: 20926204
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of beta-catenin/E-cadherin in meningiomas.
Brunner EC; Romeike BF; Jung M; Comtesse N; Meese E
Histopathology; 2006 Aug; 49(2):178-87. PubMed ID: 16879395
[TBL] [Abstract][Full Text] [Related]
9. Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas.
Müller P; Henn W; Niedermayer I; Ketter R; Feiden W; Steudel WI; Zang KD; Steilen-Gimbel H
Clin Cancer Res; 1999 Nov; 5(11):3569-77. PubMed ID: 10589773
[TBL] [Abstract][Full Text] [Related]
10. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
[TBL] [Abstract][Full Text] [Related]
11. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
Ruttledge MH; Sarrazin J; Rangaratnam S; Phelan CM; Twist E; Merel P; Delattre O; Thomas G; Nordenskjöld M; Collins VP
Nat Genet; 1994 Feb; 6(2):180-4. PubMed ID: 8162072
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the NF2 gene in sporadic meningiomas by denaturing high-performance liquid chromatography.
Kim JH; Kim IS; Kwon SY; Jang BC; Suh SI; Shin DH; Jeon CH; Son EI; Kim SP
Int J Mol Med; 2006 Jul; 18(1):27-32. PubMed ID: 16786152
[TBL] [Abstract][Full Text] [Related]
14. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
[TBL] [Abstract][Full Text] [Related]
15. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
16. NF2 status of meningiomas is associated with tumour localization and histology.
Kros J; de Greve K; van Tilborg A; Hop W; Pieterman H; Avezaat C; Lekanne Dit Deprez R; Zwarthoff E
J Pathol; 2001 Jul; 194(3):367-72. PubMed ID: 11439370
[TBL] [Abstract][Full Text] [Related]
17. Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q.
Mrózek K; Heinonen K; Theil KS; Bloomfield CD
Genes Chromosomes Cancer; 2002 Jun; 34(2):137-53. PubMed ID: 11979548
[TBL] [Abstract][Full Text] [Related]
18. Cytogenical analysis of brain tumors by FISH (fluorescence in situ hybridization) and FCM (flow cytometry).
Kasai H; Kawamoto K
Noshuyo Byori; 1995 Mar; 12(1):75-82. PubMed ID: 7795734
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide genetic characterization of an atypical meningioma by single-nucleotide polymorphism array-based mapping and classical cytogenetics.
Krupp W; Holland H; Koschny R; Bauer M; Schober R; Kirsten H; Livrea M; Meixensberger J; Ahnert P
Cancer Genet Cytogenet; 2008 Jul; 184(2):87-93. PubMed ID: 18617056
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetics and molecular genetics of nervous system tumors.
Rey JA; Pestaña A; Bello MJ
Oncol Res; 1992; 4(8-9):321-31. PubMed ID: 1336685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
